xbridge ost c method guidelines 18 - waters … · document provides useful method guidelines for...

[ method guidelines ]

XBridge™ OST C18 columns are based on Waters second generation of

hybrid-silica BEH Technology™ particles and can be effectively used

for the lab scale purification and analysis of detritylated synthetic

oligonucleotides using ion-pair, reversed-phase chromatography. This

document provides useful method guidelines for the effective use of

this column chemistry for this group of compounds.

Cont ents

I. PRINCIPLES OF OLIGONUCLEOTIDE SEPARATIONS

II. SAMPLE PREPARATION

III. RECOMMENDED MOBILE PHASES

IV. RECOMMENDED INJECTOR WASH SOLVENT

V. GENERAL CONSIDERATIONS IN DEVELOPING SEPARATIONS

VI. ANALYSIS OF MODIFIED OLIGONUCLEOTIDES

VII. PURIFICATION CONSIDERATIONS

XBridge™ ost C18 Method guidelines

*ost: oligonuCleot ide separat ion t eChnology

2


i . p rinCiples oF oligonuCleot ide separat ions Separations of detritylated synthetic oligonucleotides on an XBridge™

OST C18 column are based on ion-pair, reversed-phase chromatographic

principles (IP-RP-LC). As shown in Figure 1, the ion-pairing additive in

the mobile phase is adsorbed on a hydrophobic sorbent and provides

for charge-to-charge interactions with negative charges contained on

the oligonucleotide backbone (e.g., phosphate groups).

Figure 1: Proposed Mechanism of IP-RP-LC for Synthetic Oligonucleotide Separations

As a result, an efficient charge-based (length-based) oligonucleotide

separation is achieved (Figure 2). Gradient elution using an acetonitrile

or methanol eluent displaces both ion-pairing agent and the oligo-

nucleotides from the sorbent surface.

Separation selectivity and resolution decreases with increasing

oligonucleotide length (Figure 2) making the separation of long

oligonucleotides challenging. Modified oligonucleotides such as phos-

phorothioates and 2-O alkyl modified species are also more difficult

to analyze. Special mobile phase may be required (see Section III,

Recommended Mobile Phases).

Figure 2: Separation of a 15 - 60mer Deoxythymidine Ladder on XBridge™ OST C

18

HPLC system: Waters BioAlliance™ 2796, PDA Detector with micro UV cell Sample Injected: Approximately 100 pmoles of a detritylated 15 – 60mer oligonucleotide ladder diluted in 0.1 M TEAAColumn: Waters XBridge™ OST C18, 2.5 µm (2.1 x 50 mm)Mobile Phases: A: 0.1 M TEAA, B: Acetonitrile / 0.1M TEAA, 20/80, v/v Flow rate: 0.2 mL/min Column Temp.: 60 ˚C Gradient delay: 0.45 mLGradient: 40 to 62.5% B in 30 minutes (8-12.5% acetonitrile, 0.15% acetonitrile per minute) Detection: 260 nm, 5 scans per second

Two commonly used ion-pairing agents for oligonucleotide applications

are triethyl ammonium and dimethylbutyl ammonium ions. The final pH of

these mobile phases containing either of these ion-pairing reagents is

adjusted by the addition of Acetic Acid, or in some cases, Hexafluo-

roisopropanol (HFIP). These mobile phases are volatile making them

suitable for LC-MS applications.

The ability to adequately resolve synthetic oligonucleotide mixtures

by ion-pair, reversed-phase chromatography is significantly affected

by the particle size of the material contained in an efficiently packed

column (see Figure 3). Consequently, XBridge™ OST C18 columns are

efficiently packed with 2.5 micron material to maximize detritylated

oligonucleotide component resolution. In order to improve oligonucleotide

separation efficiency and speed, elevated separation temperature (e.g.

60 ˚C) is recommended. Elevated temperature will also reduce operating

LC System back pressure.

++

+ + - -

- -

- - -

- +

T EA

XBridge™ OST C18

chain PO group on Oligo chain

3


Figure 3: Effectiveness of Waters BEH Technology™ Hybrid-Silica C18

Particle Size on Deoxythymidine Ladder Separations

HPLC system: Waters BioAlliance™ 2796, PDA Detector with micro UV cell Sample Injected: Approximately 100 pmoles of detritylated 15 – 60mer crude oligonucleotide ladder diluted in 0.1 M TEAAColumn: Waters BEH Hybrid-Silica C18 particles (2.1 x 50 mm)Mobile Phases: A: 0.1 M TEAA, B: Acetonitrile / 0.1M TEAA, 20/80, v/v Flow rate: 0.2 mL/minColumn Temp.: 60 ˚C Gradient delay: 0.45 mLGradient: 40 to 62.5% B in 30 minutes (8-12.5% acetonitrile, 0.15% acetonitrile per minute) Detection: 260 nm, 5 scans per second

In addition to ion-pairing, a hydrophobic reversed-phase mechanism

also takes place in the oligonucleotide separation. The residual interaction

of nucleobases has an impact on overall retention and separation

selectivity, especially when using Triethylammonium Acetate (TEAA)

ion-pairing mobile phases. Separation of N and N-1mers may be either

enhanced or suppressed by the sequence contribution. More potent

ion-pairing systems such as Triethylammonium ion with Hexafluo-

roisopropanol counter ion provide for more regular “charge-based”

separations (Figure 4).

Figure 4: Impact of Ion-pairing System on Separation of a 10-30mer Heterooligonucleotide Ladder

HPLC system: Waters BioAlliance™ 2796, PDA Detector with micro UV cell Sample: 20 mer: TCC CTA GCG TTG AAT TGT CC 25 mer: TCC CTA GCG TTG AAT TGT CCC TTA G 30 mer: TCC CTA GCG TTG AAT TGT CCC TTA GCG GGT Ladder was prepared by hydrolyzing detritylated 20, 25, and 30mer oligonucleotides with a 3’-exonucleaseColumn: Waters XBridge™ OST C18, 2.5 µm (4.6 x 50 mm)Mobile phases: Upper chromatogram: 0.1 M TEAA with acetonitrile gradient; Lower chromatogram: 16.3 mM TEA - 400 mM HFIP with methanol gradientFlow rate: 1.0 mL/min Column Temp.: 60 ˚C Gradient delay: 0.45 mLDetection: 260 nm, 5 scans per second

i i . saMple p reparat ion

1. Dissolve the detritylated synthetic oligonucleotide sample in Mobile

Phase A (e.g., 0.1 M TEAA). For example, a 0.05 - 0.2 µmole scale

synthesis can be prepared in 0.1 mL of 0.1 M TEAA. Proportionately

larger or smaller volumes of 0.1M TEAA are required when dissolving

samples from different scale syntheses. Due to the nature of gradient

separations, relatively large volumes of sample (in low organic

strength eluent) can be injected and concentrated onto the head of

the column before beginning the gradient elution program.

2. Samples must be completely in solution and free of particulates

before injecting onto the column. Remove all particles from the

sample (Controlled Pore Glass Synthesis Support, etc.), which may

block the inlet column frit, increase the operating pressure, and

shorten the column life time. Sample contamination with high con-

centration of salts and/or detergents may also interfere with analysis.

4


3. To remove particulates the sample may be filtered with a 0.2 μm

membrane. Be sure that the selected membrane is compatible and

does not dissolve with the selected Mobile Phase diluent. Contact

the membrane manufacturer with solvent compatibility questions.

An alternative method of particulate removal involves centrifugation

for 20 minutes at 8,000 rpm, followed by the transfer of the supernatant

liquid to an appropriate vial.

i i i . reCoMMended MoBile phases The most common ion-pair mobile phase for synthetic oligonucleotide

separations is based on Triethylammonium Acetate (TEAA). This

mobile phase can be prepared by titrating Glacial Acetic Acid aqueous

solution with Triethylamine (TEA).

Note: To maximize column life, it is ESSENTIAL that all prepared OST Mobile Phases be filtered through a solvent compatible, 0.45 µm mem-brane and contained in bottles that are clean and particulate free.

TEAA1L of 0.1 M TEAA may be prepared as follows:

1) Perform work in a hood.

2) Add 5.6 mL of glacial Acetic Acid into 950 mL of water and mix well.

3) Slowly add 13.86 mL of TEA.

4) The pH should be adjusted to pH 7 +/- 0.5 by careful addition

of Acetic Acid.

5) Adjust final volume to 1 L with water.

Alternatively, premixed TEAA can be used [(e.g., Sigma 1 M TEAA

(part no. 90357)]. Mix 100 mL with 900 mL of water to prepare 1 L of

0.1 M TEAA mobile phase.

Alternative ion-pairing reagents are recommended for improved sepa-

ration of phosphorothioates or when performing LC-MS analyses. An

ion-pairing mobile phase based on Triethylamine (TEA) and Hexafluo-

roisopropanol (HFIP) as the buffering acid produces an efficient eluent

system for improved separations involving these application types.

As indicated below, two ion-pairing systems are useful.

For routine detritylated oligonucleotide applications, aqueous buffer

consisting of 8.6 mM TEA and 100 mM HFIP is effective. For applications

such as those involving the separation of G-rich oligonucleotides, it is

advisable to use aqueous buffer consisting of 15 mM TEA and 400

mM HFIP (pH 7.9).

TEA-HFIP System 11L of 8.6 mM TEA / 100 mM HFIP is prepared as follows:

1) Perform work in a hood

2) Add 10.4 mL of HFIP (16.8 g) into 988.4 g of water and mix well.

3) Slowly add 1.2 mL of TEA.

4) The pH is approximately 8.3 +/- 0.1.

TEA-HFIP System 21 L of 15 mM TEA / 400 mM HFIP is prepared as follows:

1) Perform work in a hood

2) Add 41.56 mL (67.17 g) of HFIP into 956.36 g of water and mix well.

3) Slowly add 2.08 mL (1.52 g) of TEA.

4) The pH of final buffer is approximately 7.9 +/- 0.1.

iV. reCoMMended inJeCtor Wash solV entsBetween analyses, the HPLC system injector seals should be washed. A

90% Water / 10% Acetonitrile injector wash solvent is recommended.

V. general Consideration in deVeloping separationsSeparation of detritylated synthetic oligonucleotides by ion-pair,

reversed-phase chromatography uses very shallow gradients. With

both TEAA and TEA-HFIP ion-pairing systems, a rate of strong eluent

change between 0.1-0.25 % Acetonitrile (or Methanol) per minute is

recommended. However, the formation of shallow gradients can place

performance demands on LC pumps and mixers that can compromise

the quality of the separation. Consequently, it is strongly advised

that Mobile Phase B formulation contain a premix blend of aqueous

and organic solvents (e.g., Mobile Phase A= 0.1 M TEAA and Mobile

Phase B = Acetonitrile / 0.1M TEAA, 20/80, v/v) to minimize poten-

tially inadequate solvent mixing that can compromise component

resolution.

5


As illustrated in Figures 5 through 7, these analyses were performed

with the following mobile phases:

Mobile Phase A: 0.1 M TEAA

Mobile Phase B: Acetonitrile (ACN) containing 0.1 M TEAA, 20:80 (v:v)

The 0.1% ACN / min gradient change from an initial 5 to 10% Acetonitrile

concentration over 50 minutes was programmed as specified in Table 1:

Table 1

Time % A % B Actual Acetonitrile (ACN) Concentration

0 min 75 25 5%

50 min 50 50 10%

Example:

For the initial 5% Acetonitrile concentration:

Initial %B = desired ACN % / Volume Fraction of ACN in Mobile Phase

B. So, initial %B = 5% / 0.2 = 25%

For the final 10% Acetonitrile concentration:

Final %B = desired ACN % / Volume Fraction of ACN in Mobile Phase

B. So, final %B = 10% / 0.2 = 50%

With TEAA mobile phases, the unmodified oligonucleotides elute

within a 7-10 % ACN gradient window. However, C and G rich oligo-

nucleotide sequences are generally less retained (i.e., elute within a

5-8% ACN gradient window) than A and T rich sequences (i.e., elute

within a 8-11% ACN gradient span). When using a shallow gradient,

the total length of analysis for an unknown sample sequence may be

excessive. Use of a fast scouting gradient with a 1% ACN per minute

change is recommended in such cases. Information gathered from this

scouting analysis can then be used to create a more appropriate and

time efficient set of gradient conditions for the particular sample.

Gradient slope has a direct impact on the achievable oligonucleotide

component resolution (along with the type of ion-pairing agent,

sequence, and oligonucleotide modification). Steeper gradients (e.g.,

1% ACN change per minute on a 4.6 x 50mm column at a 1.0 mL/min

flow) are recommended for labeled oligonucleotides or for short, 5-15

mer sequences. Separation of longer sequences are typically performed

using more shallow gradient slopes (e.g. 0.15% ACN change per minute

on a 4.6 x 50mm column at a 1.0 mL/min flow).

The organic solvent concentration at initial sample loading conditions

has to be well chosen. If the initial organic solvent strength is too

high, then some desired oligonucleotide sequences may be unretained.

In the other extreme, when the gradient starts with too low an organic

concentration, the analysis is excessively long without the benefit

of enhanced component resolution. A suitable gradient separation

method can be approximated from the oligonucleotide base (C, G, A,

and T) composition. The initial gradient is typically adjusted while

keeping the gradient slope constant.

Table 2: Suggested Gradient Conditions for Non-Standard Detritylated Synthetic Oligonucleotide Sequences

Gradient 1 [Standard

oligonucleotides (1)]

Gradient 2 [High GC content or short


Gradient 3 [High AT content or long


Initial % ACN 7.00% 5.25% 7.50%

Final % ACN 10.75% 9.00% 12.50%

Gradient Length(4) 15 min 15min 20min

1: Standard oligonucleotides: 10 – 30mers

2: Short oligonucleotides: Less than 10mer

3: Long oligonucleotides: 30 – 60mers

4: Assuming use of a 2.1 x 50mm XBridge™ OST C18 column at a flow

of 0.2 mL/min and a separation temperature of 60 ˚C.

The retention of single and dual dye-labeled oligonucleotides is dictated

by the nature of label. For example, the retention of 25 mer oligonu-

cleotide increases according to the type of label attached as follows:

no label<6FAM< <TAMRA<TET<HEX<Cy3.

V i. analysis oF ModiF ied oligonuCleot idesXBridge™ OST C18 columns are suitable for analysis of unmodified as

well as modified detritylated oligodeoxyribonucleotides and oligoribo-

nucleotides. Phosphorothioate and 2’-O -alkyl modified oligonucleotides

can also be analyzed with IP-RP-HPLC method. However, these full

length oligonucleotide products are usually more difficult to resolve

from their shorter length failure sequences. The recommended ion-pair

system for phosphorothioate oligonucleotide analysis is TEA-HFIP (see

Recommended mobile phases). An example of a 25mer phosphorothioate

oligonucleotide analysis is shown in Figure 5.

6


Figure 5: Analysis of a Digested 25mer Phosphorothioate Oligonucleotide

HPLC system: Waters BioAlliance™ 2796, PDA Detector with micro UV cell Sample: Detritylated 25mer phosphorothioate oligonucleotide mix (CTC TCG CAC CCA TCT CTC TCC TTC T) digested with 3’ exonucleaseColumn: XBridge™ OST C18, 2.5 µm (2.1 x 50 mm)Mobile phase: A: 15 mM TEA with 400 mM HFIP B: methanolFlow rate: 0.2 mL/minColumn Temp.: 60 ˚CGradient delay: 0 mL Gradient: 15 to 20% B in 20 minutes (0.25% methanol per minute)Detection: 260 nm, 2 scans per second

Peptide nucleic acids (PNA) can also be analyzed using XBridge™ OST C18

columns. The ion-pairing system recommended for analysis of PNA is

similar to those used for peptide analysis (0.1% Trifluoroacetic Acid

or Formic Acid).

UV detection of eluted oligonucleotide peaks is often performed at

260 nm. Injection of 50 pmol of detritylated oligonucleotide sample

on a 2.1 x 50mm XBridge™ OST C18 column yields relatively abundant

peaks. Limits of quantitation (LOQ) vary with the type of oligonucleotide,

LC system and detector; LOQ generated on Waters 2996 PDA detector

equipped with micro UV cell is approximately 1 pmol (2.1 x 50mm

XBridge™ OST C18). The Limit of detection (LOD) estimate is shown in

Figure 6.

Figure 6: Analysis of a 20mer Oligodeoxythymidine Crude Synthesis Mixture

HPLC system: Waters BioAlliance™ 2796, PDA Detector with micro UV cellSample: ~600 pmol of a detritylated 20mer, ~18 pmol of 19mer, ~4.5 pmol of 17mer was injected on column.Column: XBridge™ OST C18, 2.5 µm (2.1 x 50mm)Mobile phase: A: 0.1 M TEAA, B: Acetonitrile / 0.1M TEAA, 20/80 (v/v) Flow rate: 0.2 mL/min Column Temp: 60 ˚CGradient Delay: 0 mLGradient: 35 to 50% B in 30 minutes (7-10% acetonitrile)Detection: 260 nm, 2 scans per second

V ii. puriF iCat ion Considerat ionsXBridge™ OST C18 columns are designed for laboratory scale oligo-

nucleotide purifications and analyses. Sufficient amount of isolated

material suitable for molecular biology and other experiments can

be prepared in a single injection. For example, a 4.6 X 50 mm XBridge™

OST C18 column can suitably purify approximately 20-200 nmoles of

sample in a single injection. It is important to understand that column

overloading results in a peak broadening and that some earlier eluting

impurities may co-elute with the component of interest. With a proper

heart-cutting technique, a good purity of the target oligonucleotide

can be obtained without significant yield sacrifice (Figure 7).

Chromatographers frequently develop a separation on the analytical

scale before moving to preparative work. The steps required to opti-

mize the analytical separation involve:

1) Selecting the appropriate column packing material and mobile phase.

2) Determining the optimal flow rate, gradient during and separation

temperature.

3) Determining the amount of material that can be satisfactorily

loaded and separated on the analytical scale column.

7


Once the separation has been optimized, one begins preparing for the

preparative separation. The steps to successfully scale a separation

from an analytical to a preparative column, containing the same packing

material composition, are detailed below

Step A: Calculate the flow rate for use on the Preparative column.

Preparative Column Flow Rate =

Analytical Column Flow Rate x (Diameter of Prep Column)2

(Diameter of Anal Column)2

Step B: To get similar chromatography, the gradient elution profile

should be created on both columns using the same number of column

volumes. When the analytical and preparative columns are of the

same length, as is recommended for this application, then the gradient

duration should be the same.

Note: This assumes use of the same flow rate linear velocity for both runs as calculated above. For preparative runs, it is also important to note that an initial gradient delay is required to allow the entire sample to load onto the head of the column prior to beginning chromatography.

Step C: The last calculation involves determining how much sample

can be loaded on the preparative column. This calculation compares

the relative volumes of the two columns assuming that both columns

are the same length as recommended for this application.

Preparative Column Sample Load =

Previously Determined Analytical Column Sample Load x (Diameter of Prep Column)2

(Diameter of Anal Column)2

Table 3: XBridge™ OST C18 Column Selection Guide for Detritylated

Oligonucleotide Purification

Column (mm) Approx Mass Load (µmoles)** Flow Rate (mL/min)

2.1 x 50 0.04 0.2

4.6 x 50 0.20 1.0

10.0 x 50 1.00 4.5

19.0 x 50* 4.00 16.0

30.0 x 50* 9.00 40.0

50.0 x 50* 25.00 110.0

* XBridge™ OST C18 Custom Column

** Values are only approximate and vary depending on detritylated oligonucleotide length, base composition, and “heart-cutting” fraction collection method used

Figure 7 shows the separation of 90 nmoles of a detritylated 30 mer deoxythymidine crude reaction mixture on a 4.6 x 50mm XBridge™

OST C18 column. The collection interval is suggested by the lines. Due to partial column overloading, the N -1, N -2... impurities are partially displaced and elute earlier than expected. With the proper hearth-cutting technique, 95-98% purity is typically achieved for 15-35 mer oligo-nucleotides at this purification scale.

Figure 7: Purification of a Detritylated 30mer Deoxythymidine Sample

HPLC system: Waters BioAlliance™ 2796, PDA Detector with micro UV cell Sample: Crude detritylated 30mer oligothymidine, 200 nmole dissolved in 100 µl of mobile phase A, 45 µl was injected on columnColumn: XBridge™ OST C18, 2.5 µm (4.6 x 50mm)Mobile phase: A: 0.1M TEAA with 400 mM HFIP B: Acetonitrile/0.1M TEAA, 20/80 (v/v)Flow rate: 1.0 mL/minColumn Temp.: 60 ˚CGradient delay: 0 mL (compensated)Gradient: 35 to 65% B in 24 minutes (7-13% ACN, 0.25% ACN per minute)Detection: 260 nm, 2 scans per second

Table 4: Ordering Information

Description Particle Size Pore Size Dimension Part No.

XBridge™ OST C18 2.5 μm 135Å 2.1 x 50 mm 186003952



Custom XBridge™ OST C18

-- -- -- 186003955

Waters Corporation 34 Maple Street Milford, MA 01757 U.S.A. T: 1 508 478 2000 F: 1 508 872 1990 www.waters.com


Waters, XBridge, BEH Technology and BioAlliance are trademarks of Waters Corporation.

©2008 Waters Corporation. April 2008 715001476 Rev B SC

Australia Waters Australia Pty. Limited Tel: 2 9933 1777 Fax: 2 9898 1455

Austria and European Export (Central South Eastern Europe, CIS and Middle East) Tel: 431 877 18 07 Fax: 431 877 18 08

Belgium Waters S.A.-N.V. Tel: 32 2 726 1000 Fax: 32 2 726 1100

Brazil Waters Technology Tel: 55 11 5094 3788 Fax: 55 11 5093 6413

Canada Waters Limited Tel: 800 252 4752 Fax: 905 678 9237

China Waters Technologies (Shanghai) Limited Tel: 8621 6495 6999 Fax: 8621 6495 1999

CIS/Russia Tel: +7 495 727 4490 Fax: +7 495 336 7000

Czech Republic Tel: 42 02 617 11384 Fax: 42 02 617 11386

Denmark Waters A/S Tel: 45 46 59 8080 Fax: 45 46 59 8585

Finland Waters Finland Tel: (09) 5659 6288 Fax: (09) 5659 6282

France Waters S.A Tel: (33) 1 30 48 72 00 Fax: (33) 1 30 48 72 01

Germany Waters GmbH Tel: 49 6196 400600 Fax: 49 6196 4006010

Hungary Tel: 36 1 350 5086 Fax: 36 1 350 5087

Hong Kong Waters China Ltd. Tel: 852 29 64 1800 Fax: 852 25 49 6802

India Waters India Pvt. Ltd. Tel: 91 80 2 837 1900 Fax: 91 80 2 839 2157

Ireland Waters Chromatography Ireland Ltd. Tel: 353 1 448 1500 Fax: 353 1 448 1510

Italy Waters S.P.A. Tel: 39 02 274 211 Fax: 39 02 250 1827

Japan Nihon Waters K.K. Tel: (81) 3 3471 7191 Fax: (81) 3 3471 7118

Korea Waters Korea Limited, Tel: (82) 2 820 2700 Fax: (82) 2 820 2730

Mexico Waters S.A. DE C.V. Tel: 5255 5200 1860 Fax: 5255 5524 9376

The Netherlands Waters Chromatography B.V. Tel: +31 (0)76-50 87 200 Fax: +31 (0)76-50 87 280

Norway Waters AS Tel: 47 63 84 60 50 Fax: 47 63 84 60 51

Poland Tel: (48) 22 833 4400 Fax: (48) 22 833 0987

Puerto Rico Waters Technologies Corporation Tel: 787 747 8445 Fax: 787 747 8448

Singapore Waters Asia Ltd. Tel: 65 6273 1221 Fax: 65 6273 6116

Spain Waters Cromatografía, S.A. Tel: 34 93 600 93 00 Fax: 34 93 600 93 60

Sweden Waters Sverige AB Tel: 46 8 555 11500 Fax: 46 8 555 11550

Switzerland Waters AG Tel: 41 62 889 2030 Fax: 41 62 889 2059

Taiwan Tel: 886 2 2543 1898 Fax: 886 2 2543 1918

United Kingdom Waters U.K. Ltd. Tel: 44 208 238 6100 Fax: 44 208 207 7070

All Other Countries

Waters Corporation 34 Maple Street Milford, MA 01757 USA Tel: 508 478 2000 800 252 4752 Fax: 508 872 1990

http://www.waters.com

sales oFF iC es

xbridge ost c method guidelines 18 - waters … · document provides useful method guidelines for...

Documents